ConductScience.org, home

Paper · 8030745

Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences.

Kim H and 3 others. Am J Pathol, 1994. Cited by 753 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Papers, record 8030745. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8030745

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences.
PubMed
Journal
Am J Pathol
PubMed
Year
1994
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
753
iCite
Relative citation ratio, by iCite
16.1
iCite
Revised in PubMed
2022-04-08
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kim HH
2Jen JJ
3Vogelstein BB
4Hamilton SRS R

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CarcinomaMajor topic
Colorectal NeoplasmsMajor topic
DNA ReplicationMajor topic
DNA, NeoplasmMajor topic
DNA, SatelliteMajor topic
Adult
Age Factors
Aged
Aged, 80 and over
Female
Humans
Male
Middle Aged
Prospective Studies

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P50 CA62924NCI NIH HHSUnited StatesP50CA062924PubMed and NIHNIH RePORTER
R01 CA47527NCI NIH HHSUnited StatesR01CA047527PubMed and NIHNIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in10,980,144Genetic and epigenetic modification of MLH1.https://conductscience.org/library/papers/10980144

Source PubMed

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12,876,925Oncogene alterations in primary human colon tumors.Gastroenterology1986https://conductscience.org/library/papers/2876925PubMed
22,362,940Crohn's-like lymphoid reaction and colorectal carcinoma: a potential histologic prognosticator.Mod Pathol1990https://conductscience.org/library/papers/2362940PubMed
33,557,013Protooncogene abnormalities in colon cancers and adenomatous polyps.Gastroenterology1987https://conductscience.org/library/papers/3557013PubMed
42,884,421A new prognostic classification of rectal cancer.Lancet1987https://conductscience.org/library/papers/2884421PubMed
53,587,348Prevalence of ras gene mutations in human colorectal cancers.Nature1987https://conductscience.org/library/papers/3587348PubMed
63,422,035A multivariate analysis of pathologic prognostic indicators in large bowel cancer.Cancer1988https://conductscience.org/library/papers/3422035PubMed
72,832,726Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life.Mol Cell Biol1988https://conductscience.org/library/papers/2832726PubMed
82,649,981Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas.Science1989https://conductscience.org/library/papers/2649981PubMed
91,699,228p53 mutations in colorectal cancer.Proc Natl Acad Sci U S A1990https://conductscience.org/library/papers/1699228PubMed
102,240,880Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location.Ann Intern Med1990https://conductscience.org/library/papers/2240880PubMed

Cited by241

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 753 citations.

PMIDTitleJournalYearIn PapersSource
42,488,413The characteristics of gut microbiota in colorectal cancer with different microsatellite states.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42488413PubMed
41,486,293Targeting PTPN13 with 11-amino-acid peptides of C-terminal APC prevents immune evasion of colorectal cancer.Cell Res2026https://conductscience.org/library/papers/41486293PubMed
40,914,748Harnessing biomarkers to guide immunotherapy in esophageal cancer: toward precision oncology.Clin Transl Oncol2026https://conductscience.org/library/papers/40914748PubMed
40,640,471Therapeutic targeting of mismatch repair-deficient cancers.Nat Rev Clin Oncol2025https://conductscience.org/library/papers/40640471PubMed
40,265,527Intrinsic Properties of the Lymph Node Render It Immunologically Susceptible to Metastasis.Cancer Discov2025https://conductscience.org/library/papers/40265527PubMed
39,857,073Effects of Microsatellite Instability on the Clinical and Pathological Characteristics of Colon Cancer and the Diagnostic Accuracy of Preoperative Abdominal CT Scans.Diagnostics (Basel)2025https://conductscience.org/library/papers/39857073PubMed
39,852,970
The Role of Indoxyl Sulfate in Exacerbating Colorectal Cancer During Chronic Kidney Disease Progression: Insights into the Akt/β-Catenin/c-Myc and AhR/c-Myc Pathways in HCT-116 Colorectal Cancer Cells.
Toxins (Basel)2025https://conductscience.org/library/papers/39852970PubMed
39,321,179Liver metastases and peritoneal metastases and response to checkpoint inhibitors in metastatic colorectal cancer with microsatellite instability.Oncologist2024https://conductscience.org/library/papers/39321179PubMed
39,212,927Gastrointestinal Malignancy: Genetic Implications to Clinical Applications.Cancer Treat Res2024https://conductscience.org/library/papers/39212927PubMed
39,100,666Efficacy and safety of PD-1/L1 inhibitors as first-line therapy for metastatic colorectal cancer: a meta-analysis.Front Immunol2024https://conductscience.org/library/papers/39100666PubMed

1 to 10 of 241

See all 241 cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IK3,550PubTator's text mininghttps://conductscience.org/library/genes/3550NCBI Gene
TP537,157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8030745

GET https://conductscience.org/api/papers/v1/8030745/references?page=2